Feb 2020
Conyers provided Cayman Islands legal advice to I-Mab (the Company) in connection with its successful initial public offering on Nasdaq Global Market raising approximately US$103 million.
The Company is a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders
Partner Richard Hall and Counsel Angie Chu of Conyers ’ Hong Kong office advised on the matter working alongside Skadden, Arps, Slate, Meagher & Flom.